The GLP-1 companion app for iOS and Android has reached a trailing gross revenue of $25,043, a monthly recurring revenue (MRR) of approximately $2,100, and has 347 active subscriptions. It has received over 600 ratings combined on the App Store and Google Play. The app utilizes a successful TikTok marketing funnel to attract paid users and has potential for growth through app store optimization, lifecycle marketing, pricing adjustments, partnerships, and enhanced creator distribution. The app assists users of GLP-1 medications by tracking various health metrics such as shots, food, hydration, symptoms, mood, and visible progress, with AI-assisted features to minimize manual logging. It is currently maintained with minimal operational overhead, primarily involving app-store fees, API usage costs, and a slideshow operator. The app is designed for individuals seeking assistance with medication schedules and healthy habits and is available on major mobile platforms, implementing a proven acquisition strategy via creators. Financially, the app has incurred estimated direct expenses of $9,762, attributed to platform and API fees, along with operator costs. A RevenueCat verification is in place. The sale of the app includes the transfer of iOS and Android apps, the source code, backend technology, brand assets, website files, and domains, contingent on a final transfer verification. A 14-day transition period will be provided by the seller as stipulated in the final agreement.